AnaptysBio nimmt an drei Investorenkonferenzen teil

Von Public Technologies21:37 (UTC), 10 November 2026 Aktualisiert

AnaptysBio nimmt am 17. November 2026 an der UBS Global Biopharma Conference in London teil; Daniel Fagas Kamingespräch beginnt um 16:40 Uhr GMT.
Finanzchef Chris Murphy besucht am 2. Dezember 2026 die Piper Sandler Healthcare Conference in New York: Kamingespräch um 8:00 Uhr ET, zusätzlich Investoreneinzelgespräche.
CEO Daniel Faga tritt am 2. Dezember 2026 bei der Evercore Healthcare Conference in Miami auf; das Kamingespräch startet um 10:50 Uhr ET.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AnaptysBio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611101620PRIMZONEFULLFEED9874908) on November 10, 2026, and is solely responsible for the information contained therein.